Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 30;28(2):103-109.
doi: 10.5978/islsm.19-OR-06.

Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy

Affiliations

Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy

Scott Evan Eder. Laser Ther. .

Abstract

Background and aim: We have previously reported improvement of clinical symptoms of genitourinary syndrome of menopause (GSM) at 3 and 6 months following three CO2 laser treatments. The current paper presents the results of long term follow up at 12, 15- and 18-months post laser treatment.

Methods: Twenty subjects (mean age 60.65 ± 6.34 years) who had completed the core study participated in follow-up. Subjects were evaluated at 12, 15, and 18 months following final laser therapy. An optional maintenance treatment was offered during Month 12 and Month 15 to those women who failed to increase their Vaginal Health Index Score (VHIS) by more than 34% from their individual baseline, or if the subject desired an additional treatment. At each study visit, VHIS and vulvovaginal atrophy (VVA) symptom severity were recorded. Sexual function was assessed using the Female Sexual Function Index (FSFI).

Results: Fifteen subjects were eligible for a single maintenance treatment (N = 2, at 12 months, and N = 13 at 15 Months). The mean VHIS (± standard deviation) remained significantly improved at 12 months following their last laser treatment (16.3 ± 4.5 vs. Baseline 12.4 ± 4.0; p < 0.05) and at the 15- and 18-months follow up visits as well (16.9 ± 4.6 and 17.1 ± 4.6, respectively; p < 0.05 compared to Baseline). Almost all VVA symptoms were significantly improved at 12 months following the third treatment compared to Baseline and this improvement was sustained at 15 and 18 months. At the 12 Months visit, the total FSFI score increased significantly (N = 15, 24.4 ± 6.9; p < 0.05), and at the 15- and 18-month follow-up visits, the total FSFI remained significantly higher than Baseline (22.2 ± 6.7, 25.8 ± 6.6).

Conclusion: Fractional CO2 laser treatments are effective in alleviating symptoms of VVA and sexual dysfunction in post-menopausal women, and that effects are sustained over the long-term.

Keywords: CO2 laser; menopause; sexual function; vulvovaginal atrophy.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:
Data is presented as mean ± standard error. *Significantly different from baseline, p < 0.05.
Fig. 2:
Fig. 2:
Data measured on a VAS scale (range 0–10), is presented as mean ± standard error. *Significantly different from baseline, p <0.05.

References

    1. Heiman JR, Rupp H, Janssen E, Newhouse SK, Brauer M, Laan E. 2011. Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Hormones and behavior. 59:772-779. - PubMed
    1. Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. 2016. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. American journal of obstetrics and gynecology. 215:704-711. - PubMed
    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. 2002. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. American journal of obstetrics and gynecology. 1:116-126 - PubMed
    1. Kim H-K, Kang S-Y, Chung Y-J, Kim J-H, Kim M-R. 2015. The Recent Review of the Genitourinary Syndrome of Menopause. J Menopausal Med. 21:65-71. - PMC - PubMed
    1. Nappi RE, Palacios S. 2014. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 17:3-9. - PubMed

LinkOut - more resources